Peter Kaiser (Chief Development Officer) sold ~$70K of Ocular Therapeutix
Automatic saleLoading…
Traded Oct 2, 2026 · Filed Oct 7, 2026
Ocular Therapeutix's Chief Scientific Officer sold $77K of Ocular Therapeutix shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$76,626
Shares × reported transaction price
60 days after results of Aug 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references tax withholding
Only flagged when a footnote says so; never inferred